Free Trial
→ Musk’s Project Colossus could mint millionaires (From Brownstone Research) (Ad) Free VKTX Stock Alerts

Viking Therapeutics (VKTX) SEC Filings & 10K Form

Viking Therapeutics logo
$37.89 +2.33 (+6.55%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$38.68 +0.80 (+2.10%)
As of 08/8/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Viking Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/06/2025
11:19 AM		FMR LLC (Filed by)
Viking Therapeutics (Subject)
Form SCHEDULE 13G/A
07/23/2025
4:01 PM		Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/03/2025
2:30 PM		Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
2:31 PM		Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
2:31 PM		Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:01 PM		Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2025
12:05 PM		Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2025
12:07 PM		Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/27/2025
4:20 PM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2025
9:43 AM		FMR LLC (Filed by)
Viking Therapeutics (Subject)
Form SCHEDULE 13G/A
04/24/2025
3:37 PM		Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2025
4:25 PM		Viking Therapeutics (Filer)
Form DEFR14A
04/23/2025
4:26 PM		Viking Therapeutics (Filer)
Form DEFA14A
04/23/2025
3:01 PM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
9:00 AM		BlackRock, Inc. (Filed by)
Viking Therapeutics (Subject)
Form SCHEDULE 13G/A
04/14/2025
6:26 PM		FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
6:05 PM		Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4/A
04/08/2025
4:23 PM		Viking Therapeutics (Filer)
Form DEFA14A
04/08/2025
4:25 PM		Viking Therapeutics (Filer)
Form ARS
04/02/2025
5:29 PM		Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
6:05 AM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
3:32 PM		Viking Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/06/2025
7:15 PM		Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:16 PM		Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:11 PM		Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:12 PM		FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:13 PM		Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:13 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:14 PM		MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:14 PM		Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:32 PM		Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
4:25 PM		Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
4:16 PM		Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
5:22 PM		MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
5:13 PM		MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
12:54 PM		VANGUARD GROUP INC (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
11/04/2024
5:31 AM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
8:48 PM		Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:37 PM		Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/25/2024
6:27 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
6:28 PM		Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Why AMZN, GOOG, MSFT might destroy NVDA (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
10/25/2024
3:10 PM		Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
4:00 PM		Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2024
3:09 PM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
11:26 AM		STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
09/20/2024
8:20 PM		Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:21 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:29 PM		Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
6:23 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
6:23 PM		Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:11 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:13 PM		Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:00 PM		Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
6:47 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
7:03 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:38 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:VKTX) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...
The Oxford Club | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsored
One stock to replace Nvidia
I'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...
InvestorPlace | Sponsored
Crypto bros: Meet your replacement
Larry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...
Brownstone Research | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Utah’s New Oil Find
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...
Stansberry Research | Sponsored